Di Dalmazi Guido, Berr Christina M, Fassnacht Martin, Beuschlein Felix, Reincke Martin
Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, D-80336 München, Germany.
J Clin Endocrinol Metab. 2014 Aug;99(8):2637-45. doi: 10.1210/jc.2014-1401. Epub 2014 May 30.
The postoperative course of patients with subclinical hypercortisolism (SH) is yet to be clarified. The aims are to review the prevalence and predictive factors of postoperative adrenal insufficiency and the time to recover a normal adrenocortical function in patients with SH and Cushing's syndrome (CS).
Using the PubMed database, we conducted a systematic review of the literature, selecting studies published from 1980 to 2013.
Of the 1522 papers screened, 28 were selected (13 retrospective, 14 prospective, and one randomized controlled trial). The prevalence of postoperative adrenal insufficiency was 65.3% in 248 SH subjects and 99.7% in 377 CS patients. Patients with SH were reclassified according to the following diagnostic criteria: subjects defined by pathological dexamethasone test only (DEX), and those defined by the dexamethasone test with one (DEX+1) or two additional criteria (DEX+2); and they were compared with CS patients. The prevalence of adrenal insufficiency was 51.4, 60.6, 91.3, and 99.7%, respectively, with no significant difference between the two latter groups. The test with the best compromise between sensitivity (64%) and specificity (81%) in predicting adrenal insufficiency was the midnight serum cortisol. The time to achieve eucortisolism was lower in SH patients than in CS patients (6.5 vs 11.2 mo; P < .001).
Adrenal insufficiency occurs in about half of the patients with SH if defined only by the pathological dexamethasone test. However, prevalence of adrenal insufficiency and time to recovery are tightly related to the degree of hypercortisolism and diagnostic criteria to define SH, which might help to better define SH for future studies.
亚临床皮质醇增多症(SH)患者的术后病程尚未明确。目的是回顾SH和库欣综合征(CS)患者术后肾上腺功能不全的患病率及预测因素,以及恢复正常肾上腺皮质功能的时间。
我们使用PubMed数据库对文献进行了系统回顾,选取了1980年至2013年发表的研究。
在筛选的1522篇论文中,选取了28篇(13篇回顾性研究、14篇前瞻性研究和1篇随机对照试验)。248例SH患者术后肾上腺功能不全的患病率为65.3%,377例CS患者为99.7%。根据以下诊断标准对SH患者进行重新分类:仅通过病理地塞米松试验定义的患者(DEX),以及通过地塞米松试验加一项(DEX+1)或两项附加标准(DEX+2)定义的患者;并将他们与CS患者进行比较。肾上腺功能不全的患病率分别为51.4%、60.6%、91.3%和99.7%,后两组之间无显著差异。预测肾上腺功能不全时,在敏感性(64%)和特异性(81%)之间取得最佳平衡的检测方法是午夜血清皮质醇。SH患者达到正常皮质醇水平的时间比CS患者短(6.5个月对11.2个月;P<.001)。
如果仅通过病理地塞米松试验定义,约一半的SH患者会发生肾上腺功能不全。然而,肾上腺功能不全的患病率和恢复时间与皮质醇增多症的程度及定义SH的诊断标准密切相关,这可能有助于为未来的研究更好地定义SH。